Pathway Therapeutics Limited Announces Appointment of Mark Perry and Dr. Paul Goddard to its Board of Directors
8/16/2011 9:11:48 AM
More...
|
FDA Approves Trial of Pathway Therapeutics Limited Cancer Drug; $7.5 Million Financing in Place to Advance Novel PI3K/mTOR Inhibitor Portfolio
5/25/2011 6:40:20 AM
More...
|
Pathway Therapeutics Limited Completes $4.5 Million Financing for Novel PI3K Inhibitor Portfolio
8/10/2010 8:52:55 AM
More...
|
Pathway Therapeutics Limited Release: New Zealand First To Benefit From New Trans-Tasman Funding Entity
12/3/2008 2:56:12 PM
More...
|
New Zealand Company, Pathway Therapeutics Limited Raises $9.6M Series A
6/17/2008 2:51:56 PM
More...
|